Cite
Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients
MLA
Hong-Ling Peng, et al. “Use of All-Trans Retinoic Acid in Combination with Arsenic Trioxide for Remission Induction in Patients with Newly Diagnosed Acute Promyelocytic Leukemia and for Consolidation/Maintenance in CR Patients.” Acta Haematologica, vol. 121, no. 1, June 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d79c7a980e52bbd33de4a9b2d9fd7e29&authtype=sso&custid=ns315887.
APA
Hong-Ling Peng, Guang-Sen Zhang, Yun-xiao Xu, Jian-kai Shen, Ruijuan Li, Min-fei Pei, Chong-Wen Dai, Hai-ying Zhong, Wenli Zheng, Yi-Xiong Cao, Jun-jie Yang, & Yan Yi. (2008). Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients. Acta Haematologica, 121(1).
Chicago
Hong-Ling Peng, Guang-Sen Zhang, Yun-xiao Xu, Jian-kai Shen, Ruijuan Li, Min-fei Pei, Chong-Wen Dai, et al. 2008. “Use of All-Trans Retinoic Acid in Combination with Arsenic Trioxide for Remission Induction in Patients with Newly Diagnosed Acute Promyelocytic Leukemia and for Consolidation/Maintenance in CR Patients.” Acta Haematologica 121 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d79c7a980e52bbd33de4a9b2d9fd7e29&authtype=sso&custid=ns315887.